A Long-acting Human Growth Hormne (VRS-317) in Pre-pubertal Children with Growth Hormone Deficiency: A Randomized, Open-label, Multi-center, Phase 1b/2a Study of Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Efficac